CERTOLIZUMAB PEGOL FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS: 4-YEAR OUTCOMES FROM THE RAPID-AXSPA TRIAL
Author(s):
Heijde, D. van der; Dougados, M.; Landewe, R.; Sieper, J.; Maksymowych, W.P.; Rudwaleit, M.; Bosch, F. van den; Braun, J.; Mease, P.J.; Davies, O.; Hoepken, B.; Peterson, L.; Deodhar, A.
Published
2016
Publication type
Article / Letter to editor
Date issued
2016-08-31
Language
English
Is part of
Clinical and Experimental Rheumatology (2016), Vol. 34, no. 4, p. 779-779
